Abstract:Objectives To examine the frequency of re‐admissions to non‐index hospitals (hospitals other than the initial discharging hospital) within 30 days of admission with acute myocardial infarction in New South Wales; to examine the relationship between non‐index hospital re‐admissions and 30‐day mortality. Study design Retrospective cohort study; analysis of hospital admissions (Admitted Patient Data Collection) and mortality data (Registry of Births, Deaths and Marriages). Setting, participants Adults admitted to NSW hospitals with acute myocardial infarction re‐admitted to any hospital within 30 days of discharge from the initial hospitalisation, 1 January 2005 – 31 December 2020. Main outcome measures Proportion of re‐admissions within 30 days of discharge to non‐index hospitals, and associations of non‐index hospital re‐admissions with demographic and initial hospitalisation characteristics and with 30‐day and 12‐month mortality, each by residential remoteness category. Results Of 168 097 people with acute myocardial infarction discharged alive, 28 309 (16.8%) were re‐admitted to hospital within 30 days of discharge, including 11 986 to non‐index hospitals (42.3%); the proportion was larger for people from regional or remote areas (50.1%) than for people from major cities (38.3%). The odds of non‐index hospital re‐admission were higher for people with ST‐elevation myocardial infarction, for people whose index admissions were to private hospitals, who were transferred between hospitals or had undergone revascularisation during the initial admission, were under 65 years of age, or had private health insurance; the influence of these factors was generally larger for people from regional or remote areas than for those from large cities. After adjustment for potential confounders, non‐index hospital re‐admission did not influence mortality among people from major cities (30‐day: adjusted odds ratio [aOR], 1.09; 95% confidence interval [CI], 0.99–1.20; 12‐month: aOR, 0.98, 95% CI, 0.93–1.03), but was associated with reduced mortality for people from regional or remote areas (30‐day: aOR, 0.81; 95% CI, 0.70–0.95; 12‐month: aOR, 0.88; 95% CI, 0.81–0.96). Conclusions The geographically dispersed Australian population and the mixed public and private provision of specialist services means that re‐admission to a non‐index hospital can be unavoidable for people with acute myocardial infarction who are initially transferred to specialised facilities. Non‐index hospital re‐admission is associated with better mortality outcomes for people from regional or remote areas.

Burden and predictors of thirty-day readmission in patients with NSTEMI: a retrospective analysis of the 2020 NRD database

Thirty‐Day Readmission Rates, Timing, Causes, and Costs after ST‐Segment–Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010–2014

Predictors of 30-day hospital readmission after mechanical thrombectomy for acute ischemic stroke

Abstract 14962: Rate of 30-Day Readmission and Economic Burden of Sickle Cell Disease Patients Who Underwent Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Procedure for ST Elevation Myocardial Infarction

Impact of Hospital Readmissions Reduction Program Policy on 30-Day and 90-Day Readmissions in Patients With Acute Myocardial Infarction: A 10-Year Trend From the National Readmissions Database

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients With Heart Failure Exacerbation and Atrial Fibrillation: A Cross-Sectional Study

Socioeconomic and Demographic Determinants of Readmission Rates in Congestive Heart Failure Patients: Insights From the Nationwide Readmissions Database

Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act

Causes and Predictors of 30-Day Readmission in Patients With Stroke Undergoing Mechanical Thrombectomy: A Large Single-Center Experience

Abstract P251: Estimates and Temporal Trends for US Nationwide 30-Day Hospital Readmission Among Patients With Ischemic Stroke Treated With Thrombolytic Therapy

Development of a Clinical Registry-Based 30-Day Readmission Measure for Coronary Artery Bypass Grafting Surgery

Thirty-day hospital readmission in females with acute heart failure and breast cancer: A retrospective cohort study from national readmission database

Non‐index hospital re‐admissions after hospitalisation with acute myocardial infarction and geographic remoteness, New South Wales, 2005–2020: a retrospective cohort study

Impact of time from discharge to readmission on outcomes: an observational study from the US National Readmission Database

Effect of Discharge Readiness on 30-Day Readmissions Among Older Adults Living With Multiple Chronic Conditions

Abstract P253: Readmission in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment

Causes of short-term readmission after percutaneous coronary intervention

Predicting Risk Factors for 30-Day Readmissions Following Discharge From Post-Acute Care

Early (0-7 day) and late (8-30 day) readmission predictors in acute coronary syndrome, atrial fibrillation, and congestive heart failure patients

30-day Readmission Outcomes In Young Patients With Heart Failure From 2010 Through 2019 - National Readmission Database Analysis

Abstract TMP42: Reducing 30-day Stroke Readmissions Using a Multi-Step Quality Improvement Approach